QuickView for telethonin binding (biogroup)

1. L1000 CMAP - Neural progenitor NPC.CAS9 cells treated with small molecule perturbagens
2. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
3. Skin from alopecia areata allografts treated with ruxolitinib or tofacitinib
4. L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
5. Weight bearing versus protective bones from mice - ulnar, mandibular, and calvarial bones

There were no matches for telethonin binding

There were no clinical trials for telethonin binding